Related Experiment Video

Updated: Jul 17, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K

Interplay Between Anatomic and Molecular Factors in the Current Management of Endometrial Cancer

Hirsch Matani1, Sushil Beriwal1

  • 1Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania.

International Journal of Radiation Oncology, Biology, Physics
|August 31, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.3K
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:13

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

884

Related Experiment Videos

Last Updated: Jul 17, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.3K
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:13

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

884

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

Articles linked to this work by shared authors, journal, and citation graph.

Dosimetric evaluation and clinical feasibility of Halcyon-E O-ring linear accelerator for single fraction coplanar stereotactic radiosurgery.

Journal of medical imaging and radiation sciences·2026

Economics achieved through the use of artificial intelligence-powered contouring solutions in a network of oncology clinics in low- and middle-income countries.

Frontiers in oncology·2026

Outcomes of single application and three fraction hybrid MR adaptive brachytherapy in Carcinoma Cervix-Early experience from an Indian cancer center.

Brachytherapy·2026

Percutaneous coronary intervention followed by intravascular brachytherapy for management of drug-eluting stents in-stent restenosis in patients with complex coronary artery lesions.

Journal of contemporary brachytherapy·2026

Selection of hybrid applicators for adaptive cervical cancer brachytherapy: A practical guide.

Journal of contemporary brachytherapy·2026

The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation.

International journal of radiation oncology, biology, physics·2026

A Modular Multi-Agent Reinforcement Learning Framework Guided by LLMs: Improving Quality and Efficiency of Treatment Planning in Lung Radiotherapy.

International journal of radiation oncology, biology, physics·2026

A combined dose and microdosimetric modeling framework incorporating volume effects correlates with tissue sparing in proton minibeam radiotherapy.

International journal of radiation oncology, biology, physics·2026

Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.

International journal of radiation oncology, biology, physics·2026

Clinical and Treatment Factors associated with Lymphopenia after Palliative Radiation Therapy in Cancer Patients.

International journal of radiation oncology, biology, physics·2026

Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy.

International journal of radiation oncology, biology, physics·2026

Reanalysis of Mechanism-Inspired Relative Biological Effectiveness Models Based on Track-structure Monte Carlo Simulation.

International journal of radiation oncology, biology, physics·2026

ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.

Molecular cancer research : MCR·2026

pH-Responsive drug delivery system for tumor therapy.

Nanoscale·2026

Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.

Organic & biomolecular chemistry·2026

Inducible IL-12 or IL-18 secreting CAR T cells targeting the glyco-antigen CD176 exhibit potent activity against non-small cell lung cancer in preclinical models.

Cancer immunology research·2026

Targeting RAS for Pancreatic Cancer Interception.

Cancer discovery·2026

Comprehensive Genomic Profiling Beyond Driver Testing in Non-Squamous Non-Small Cell Lung Cancer With Known Drivers.

Cancer science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us